Commitments and Contingencies (Details) - AbbVie Biotherapeutics Corp [Member] - USD ($) |
12 Months Ended | |
|---|---|---|
Jul. 24, 2012 |
Dec. 31, 2016 |
|
| Phase I Clinical Trial of a licensed product [Member] | ||
| Summary of milestone payment | ||
| Milestones payments | $ 750,000 | $ 750,000 |
| Phase II Clinical Trial of a licensed product [Member] | ||
| Summary of milestone payment | ||
| Milestones payments | 750,000 | |
| Phase III Clinical Trial of a licensed product [Member] | ||
| Summary of milestone payment | ||
| Milestones payments | 1,500,000 | |
| Biological License Application filing with U.S. FDA [Member] | ||
| Summary of milestone payment | ||
| Milestones payments | 1,750,000 | |
| First commercial sale [Member] | ||
| Summary of milestone payment | ||
| Milestones payments | 1,500,000 | |
| After first net sales [Member] | ||
| Summary of milestone payment | ||
| Milestones payments | $ 1,500,000 |